Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
12/11/2025
73 Mainland Chinese Biotech/MedTech Firms Flock to Hong Kong for IPO...
12/11/2025
China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia
12/11/2025
Forward Pharma Reports Promising Early Data for Oral SERD FWD1802
12/11/2025
Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...
12/11/2025
Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
12/11/2025
Zealand and OTR Thera Form $2.5B Alliance to Develop Next-Gen Metabo...
12/11/2025
China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...
12/11/2025
Syneron Secures ~$100M to Advance Macrocyclic Peptide Drug Pipeline
12/11/2025
China Pushes Private Insurance to Cover High-Cost Innovative Drugs as ...
12/11/2025
Formation Bio Secures Global Rights to Lynk Pharma's CNS-Targeted TYK2...
12/10/2025
China's Human Vaccine Market Set for Steady Long-Term Expansion
12/10/2025
Dizal Showcases Broad ASH25 Data for Golidocitinib and Birelentinib
12/10/2025
InnoCare Highlights Strong ASH25 Data for BCL2 Inhibitor Mesutoclax
12/10/2025
Lepu Reports Encouraging Phase II Results for CD20-Targeted ADC Combo
12/10/2025
China Launches First Commercial Insurance Drug List, Spotlighting High...
12/10/2025
Pfizer Expands Obesity Pipeline With $150M Deal for Fosun Subsidiary's...
12/9/2025
Ascletis Reports Positive Phase II Results for Oral GLP-1 Agonist ASC3...
12/9/2025
US Set to Tighten Curbs on Chinese Biotech and Cross-Border Investment
12/9/2025
Former CFDA Boss Bi Jingquan Expelled From Party, Faces Bribery Charge...
12/9/2025
Pfizer, Lilly, J&J Among First Drugmakers to Secure Spots in China's N...
12/9/2025
SanegeneBio Raises $110M+ in Series B Financing to Accelerate RNAi Pip...
12/9/2025
SynRx Raises Over CNY 100M in Series A Financing to Advance DNA Damag...
12/9/2025
Embios Secures Series A Funding as It Advances CXCR3-Pathway Immunothe...
12/9/2025
Biokin Reports Strong Phase 2 Results for HER2-Targeted ADC T-Bren
12/8/2025
Pfizer Files for Approval of Zavegepant Nasal Spray in China
12/8/2025
CSPC's Semaglutide Injection Moves Forward — sNDA Accepted, Obesity I...
12/8/2025
China Releases Updated NRDL and First Commercial Insurance Innovative ...
12/5/2025
Recent Executive Moves
12/5/2025
Highlightll Pharma Files for Hong Kong IPO as It Expands Neuroinflamma...
12/5/2025
OTR Thera Secures US$100M in Series A Financing
Page:
1
/
58
Total number of articles:
1729
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit